Systematic literature review and meta-analysis of sacral neuromodulation (SNM) in patients with neurogenic lower urinary tract dysfunction (nLUTD): over 20 years' …

A van Ophoven, S Engelberg, H Lilley, KD Sievert - Advances in therapy, 2021 - Springer
Introduction Sacral neuromodulation (SNM) has been used in carefully selected patients
with neurogenic lower urinary tract dysfunctions (nLUTD) for over two decades. Methods …

The management of lower urinary tract dysfunction in multiple sclerosis

J Tornic, JN Panicker - Current neurology and neuroscience reports, 2018 - Springer
Abstract Purpose of Review Multiple sclerosis (MS) is the most frequent neuroinflammatory
disease of the central nervous system and is commonly associated with lower urinary tract …

Disorders of ejaculation: an AUA/SMSNA guideline

AW Shindel, SE Althof, S Carrier, R Chou… - Journal of …, 2022 - journals.lww.com
Purpose: Men who ejaculate before or shortly after penetration, without a sense of control,
and who experience distress related to this condition may be diagnosed with premature …

Summary of the 2024 update of the European Association of Urology Guidelines on Neurourology

AM Sartori, TM Kessler, DM Castro-Díaz, P de Keijzer… - European urology, 2024 - Elsevier
Background and objective Most patients with neurourological disorders require lifelong
medical care. The European Association of Urology (EAU) regularly updates guidelines for …

Long-term discontinuation of botulinum toxin A intradetrusor injections for neurogenic detrusor overactivity: A multicenter study

M Baron, B Peyronnet, A Aublé, J Hascoet… - The Journal of …, 2019 - auajournals.org
Purpose: Data are lacking on long-term outcomes of intradetrusor injections of botulinum
toxin A for neurogenic detrusor overactivity. The aim of this study was to assess the …

TASCI—transcutaneous tibial nerve stimulation in patients with acute spinal cord injury to prevent neurogenic detrusor overactivity: protocol for a nationwide …

V Birkhäuser, MD Liechti, CE Anderson… - BMJ open, 2020 - bmjopen.bmj.com
Introduction Neurogenic lower urinary tract dysfunction (NLUTD), including neurogenic
detrusor overactivity (NDO) and detrusor sphincter dyssynergia, is one of the most frequent …

Management of multiple sclerosis symptoms and comorbidities

WO Tobin - CONTINUUM: Lifelong Learning in Neurology, 2019 - journals.lww.com
Management of Multiple Sclerosis Symptoms and Comorbidities : CONTINUUM: Lifelong
Learning in Neurology Account Register Activate Subscription Help Subscribe American …

Disease-specific outcomes of botulinum toxin injections for neurogenic detrusor overactivity

A Kaviani, R Khavari - Urologic Clinics, 2017 - urologic.theclinics.com
Neurogenic detrusor overactivity (NDO) is a bladder dysfunction caused by a neurologic
disease such as multiple sclerosis (MS), spinal cord injury (SCI), Parkinson's disease (PD) …

Is repeat Botulinum Toxin A injection valuable for neurogenic detrusor overactivity—A systematic review and meta‐analysis

J Ni, X Wang, N Cao, J Si, B Gu - Neurourology and …, 2018 - Wiley Online Library
Aim To investigate the value of repeat botulinum toxin A (BTX‐A) injections in patients with
neurogenic detrusor overactivity (NDO). Methods We searched the PubMed, EMBASE, and …

Updates in pelvic neuromodulation: the role of pelvic neuromodulation in pelvic disorders

B Alsannan, M Banakhar, M Hassouna - Frontiers in Urology, 2024 - frontiersin.org
Pelvic disorders affecting both male and female patients are major areas of concern for
clinicians in cases where pharmacotherapy and behavioral therapy are not effective. In such …